Lunasin: A promising polypeptide for the prevention and treatment of cancer (Review)

Wan,Xing; Liu,Hong; Sun,Yong; Zhang,Jinlan; Chen,Xianbing; Chen,Ning

doi:10.3892/ol.2017.6017

Lunasin: A promising polypeptide for the prevention and treatment of cancer (Review)

Authors:
- Xing Wan
- Hong Liu
- Yong Sun
- Jinlan Zhang
- Xianbing Chen
- Ning Chen
View Affiliations

Affiliations: School of Medicine, Hubei University for Nationalities, Enshi, Hubei 445000, P.R. China, China Meat Research Centre, Beijing 100068, P.R. China, Hubei Key Laboratory of Sport Training and Monitoring, College of Health Science, Wuhan Sports University, Wuhan, Hubei 430079, P.R. China
Published online on: April 10, 2017 https://doi.org/10.3892/ol.2017.6017
Pages: 3997-4001

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Strategies for the treatment of cancer remain unsatisfactory due to the poor understanding of the complicated underlying molecular mechanisms of carcinogenesis. A number of types of cancer exhibit a marked association with dietary habits and lifestyles. Therefore, the modulation of dietary habits or lifestyles may be an effective strategy for preventing the formation and progression of cancer. Proteins and polypeptides from soybean have been developed as healthcare products due to their marked activity in inhibiting the progression of cancer at various stages. Lunasin, containing 43 amino acid residues, is one such example of a soybean‑derived polypeptide that has been demonstrated to exhibit marked anti-cancer activity. In the present review, studies of the underlying molecular mechanisms and potential advantages of lunasin in the prevention and treatment of cancer have been examined, to provide a theoretical reference for the development of natural product‑based agents or healthcare products for the prevention and treatment of cancer.

View Figures

View References

1	Razzaghi H, Quesnel-Crooks S, Sherman R, Joseph R, Kohler B, Andall-Brereton G, Ivey MA, Edwards BK, Mery L, Gawryszewski V and Saraiya M: Leading causes of cancer mortality-Caribbean region, 2003–2013. MMWR Morb Mortal Wkly Rep. 65:1395–1400. 2016. View Article : Google Scholar : PubMed/NCBI
2	Manson MM: Cancer prevention-the potential for diet to modulate molecular signalling. Trends Mol Med. 9:11–18. 2003. View Article : Google Scholar : PubMed/NCBI
3	Zhang SF, Wang XL, Yang XQ and Chen N: Autophagy-associated targeting pathways of natural products during cancer treatment. Asian Pac J Cancer Prev. 15:10557–10563. 2014. View Article : Google Scholar : PubMed/NCBI
4	Kou X, Kirberger M, Yang Y and Chen N: Natural products for cancer prevention associated with Nrf2-ARE pathway. Food Science and Human Wellness. 2:22–28. 2013. View Article : Google Scholar
5	Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015. View Article : Google Scholar : PubMed/NCBI
6	de Kok TM, van Breda SG and Manson MM: Mechanisms of combined action of different chemopreventive dietary compounds: A review. Eur J Nutr. 47 Suppl 2:S51–S59. 2008. View Article : Google Scholar
7	Chen D and Dou QP: Tea polyphenols and their roles in cancer prevention and chemotherapy. Int J Mol Sci. 9:1196–1206. 2008. View Article : Google Scholar : PubMed/NCBI
8	Yang CS, Ju J, Lu G, Xiao H, Hao X, Sang S and Lambert JD: Cancer prevention by tea and tea polyphenols. Asia Pac J Clin Nutr. 17 Suppl 1:S245–S248. 2008.
9	Fimognari C, Lenzi M and Hrelia P: Chemoprevention of cancer by isothiocyanates and anthocyanins: Mechanisms of action and structure-activity relationship. Curr Med Chem. 15:440–447. 2008. View Article : Google Scholar : PubMed/NCBI
10	Udenigwe CC and Aluko RE: Food protein-derived bioactive peptides: Production, processing, and potential health benefits. J Food Sci. 77:R11–R14. 2012. View Article : Google Scholar : PubMed/NCBI
11	Jia S, Du Z, Jiang H, Huang X, Chen Z and Chen N: Daintain/AIF-1 accelerates the activation of insulin-like growth factor-1 receptor signaling pathway in HepG2 cells. Oncol Rep. 34:511–517. 2015.PubMed/NCBI
12	Bhutia SK and Maiti TK: Targeting tumors with peptides from natural sources. Trends Biotechnol. 26:210–217. 2008. View Article : Google Scholar : PubMed/NCBI
13	de Mejia EG and Dia VP: The role of nutraceutical proteins and peptides in apoptosis, angiogenesis and metastasis of cancer cells. Cancer Metastasis Rev. 29:511–528. 2010. View Article : Google Scholar : PubMed/NCBI
14	Liu J, Jia SH, Kirberger M and Chen N: Lunasin as a promising health-beneficial peptide. Eur Rev Med Pharmacol Sci. 18:2070–2075. 2014.PubMed/NCBI
15	McCue P and Shetty K: Health benefits of soy isoflavonoids and strategies for enhancement: A review. Crit Rev Food Sci Nutr. 44:361–367. 2004. View Article : Google Scholar : PubMed/NCBI
16	Woo HD, Park S, Oh K, Kim HJ, Shin HR, Moon HK and Kim J: Diet and cancer risk in the Korean population: A meta- analysis. Asian Pac J Cancer Prev. 15:8509–8519. 2014. View Article : Google Scholar : PubMed/NCBI
17	Chi F, Wu R, Zeng YC, Xing R, Liu Y and Xu ZG: Post-diagnosis soy food intake and breast cancer survival: A meta-analysis of cohort studies. Asian Pac J Cancer Prev. 14:2407–2412. 2013. View Article : Google Scholar : PubMed/NCBI
18	Lee MM, Gomez SL, Chang JS, Wey M, Wang RT and Hsing AW: Soy and isoflavone consumption in relation to prostate cancer risk in China. Cancer Epidemiol Biomarkers Prev. 12:665–668. 2003.PubMed/NCBI
19	Yamamoto S, Sobue T, Kobayashi M, Sasaki S and S; Japan Public Health Center-Based Prospective Study on Cancer Cardiovascular Diseases G Tsugane: Soy, isoflavones, and breast cancer risk in Japan. J Natl Cancer Inst. 95:906–913. 2003. View Article : Google Scholar : PubMed/NCBI
20	Messina M and Barnes S: The role of soy products in reducing risk of cancer. J Natl Cancer Inst. 83:541–546. 1991. View Article : Google Scholar : PubMed/NCBI
21	Toyomura K and Kono S: Soybeans, soy foods, isoflavones and risk of colorectal cancer: A review of experimental and dpidemiological data. Asian Pac J Cancer Prev. 3:125–132. 2002.PubMed/NCBI
22	Clemente A and Mdel C Arques: Bowman-Birk inhibitors from legumes as colorectal chemopreventive agents. World J Gastroenterol. 20:10305–10315. 2014. View Article : Google Scholar : PubMed/NCBI
23	Galvez AF and de Lumen BO: A soybean cDNA encoding a chromatin-binding peptide inhibits mitosis of mammalian cells. Nat Biotechnol. 17:495–500. 1999. View Article : Google Scholar : PubMed/NCBI
24	Jeong HJ, Jeong JB, Kim DS, Park JH, Lee JB, Kweon DH, Chung GY, Seo EW and de Lumen BO: The cancer preventive peptide lunasin from wheat inhibits core histone acetylation. Cancer Lett. 255:42–48. 2007. View Article : Google Scholar : PubMed/NCBI
25	Jeong HJ, Lee JR, Jeong JB, Park JH, Cheong YK and de Lumen BO: The cancer preventive seed peptide lunasin from rye is bioavailable and bioactive. Nutr Cancer. 61:680–686. 2009. View Article : Google Scholar : PubMed/NCBI
26	de Mejia E Gonzalez, Vásconez M, de Lumen BO and Nelson R: Lunasin concentration in different soybean genotypes, commercial soy protein, and isoflavone products. J Agric Food Chem. 52:5882–5887. 2004. View Article : Google Scholar : PubMed/NCBI
27	Jeong HJ, Lam Y and de Lumen BO: Barley lunasin suppresses ras-induced colony formation and inhibits core histone acetylation in mammalian cells. J Agric Food Chem. 50:5903–5908. 2002. View Article : Google Scholar : PubMed/NCBI
28	Jeong HJ, Park JH, Lam Y and de Lumen BO: Characterization of lunasin isolated from soybean. J Agric Food Chem. 51:7901–7906. 2003. View Article : Google Scholar : PubMed/NCBI
29	Rizzello CG, Nionelli L, Coda R and Gobbetti M: Synthesis of the cancer preventive peptide lunasin by lactic acid bacteria during sourdough fermention. Nutr Cancer. 64:111–120. 2012. View Article : Google Scholar : PubMed/NCBI
30	Guijarro-Díez M, García MC, Crego AL and Marina ML: Off-line two dimensional isoelectrofocusing-liquid chromatography/mass spectrometry (time of flight) for the determination of the bioactive peptide lunasin. J Chromatogr A. 1371:117–124. 2014. View Article : Google Scholar : PubMed/NCBI
31	Hsieh CC, Hernándz-Ledesma B, Jeong HJ, Park JH and de Lumen BO: Complementary roles in cancer prevention: Protease inhibitor makes the cancer preventive peptide lunasin bioavailable. PLoS One. 5:e88902010. View Article : Google Scholar : PubMed/NCBI
32	Jeong JB, Jeong HJ, Park JH, Lee SH, Lee JR, Lee HK, Chung GY, Choi JD and de Lumen BO: Cancer-preventive peptide lunasin from Solanum nigrum L. inhibits acetylation of core histones H3 and H4 and phosphorylation of retinoblastoma protein (Rb). J Agric Food Chem. 55:10707–10713. 2007. View Article : Google Scholar : PubMed/NCBI
33	Dia VP, Torres S, de Lumen BO, Erdman JW Jr and De Mejia EG: Presence of lunasin in plasma of men after soy protein consumption. J Agric Food Chem. 57:1260–1266. 2009. View Article : Google Scholar : PubMed/NCBI
34	Park JH, Jeong HJ and Lumen BO: In vitro digestibility of the cancer-preventive soy peptides lunasin and BBI. J Agric Food Chem. 55:10703–10706. 2007. View Article : Google Scholar : PubMed/NCBI
35	Jiang Q, Pan Y, Cheng Y and Li H, Liu D and Li H: Lunasin suppresses the migration and invasion of breast cancer cells by inhibiting matrix metalloproteinase-2/-9 via the FAK/Akt/ERK and NF-kB signaling pathways. Oncol Rep. 36:253–262. 2016.PubMed/NCBI
36	Hsieh CC, Hernandez-Ledesma B and de Lumen BO: Soybean peptide lunasin suppresses in vitro and in vivo 7,12-dimethylbenz[a]anthracene-induced tumorigenesis. J Food Sci. 75:H311–H316. 2010. View Article : Google Scholar : PubMed/NCBI
37	Hsieh CC, Hernandez-Ledesma B and de Lumen BO: Lunasin-aspirin combination against NIH/3T3 cells transformation induced by chemical carcinogens. Plant Foods Hum Nutr. 66:107–113. 2011. View Article : Google Scholar : PubMed/NCBI
38	Hernandez-Ledesma B, Hsieh CC and de Lumen BO: Relationship between lunasin's sequence and its inhibitory activity of histones H3 and H4 acetylation. Mol Nutr Food Res. 55:989–998. 2011. View Article : Google Scholar : PubMed/NCBI
39	Hsieh CC, Hernandez-Ledesma B and de Lumen BO: Lunasin, a novel seed peptide, sensitizes human breast cancer MDA-MB-231 cells to aspirin-arrested cell cycle and induced apoptosis. Chem Biol Interact. 186:127–134. 2010. View Article : Google Scholar : PubMed/NCBI
40	Wang W, Bringe NA, Berhow MA and de Mejia E Gonzalez: beta-Conglycinins among sources of bioactives in hydrolysates of different soybean varieties that inhibit leukemia cells in vitro. J Agric Food Chem. 56:4012–4020. 2008. View Article : Google Scholar : PubMed/NCBI
41	de Mejia EG, Wang W and Dia VP: Lunasin, with an arginine-glycine-aspartic acid motif, causes apoptosis to L1210 leukemia cells by activation of caspase-3. Mol Nutr Food Res. 54:406–414. 2010. View Article : Google Scholar : PubMed/NCBI
42	Galvez AF, Chen N, Macasieb J and de Lumen BO: Chemopreventive property of a soybean peptide (lunasin) that binds to deacetylated histones and inhibits acetylation. Cancer Res. 61:7473–7478. 2001.PubMed/NCBI
43	Hsieh EA, Chai CM, de Lumen BO, Neese RA and Hellerstein MK: Dynamics of keratinocytes in vivo using HO labeling: A sensitive marker of epidermal proliferation state. J Invest Dermatol. 123:530–536. 2004. View Article : Google Scholar : PubMed/NCBI
44	Dwarakanath BS, Verma A, Bhatt AN, Parmar VS and Raj HG: Targeting protein acetylation for improving cancer therapy. Indian J Med Res. 128:13–21. 2008.PubMed/NCBI
45	Dalvai M and Bystricky K: The role of histone modifications and variants in regulating gene expression in breast cancer. J Mammary Gland Biol Neoplasia. 15:19–33. 2010. View Article : Google Scholar : PubMed/NCBI
46	Strahl BD and Allis CD: The language of covalent histone modifications. Nature. 403:41–45. 2000. View Article : Google Scholar : PubMed/NCBI
47	Muraoka M, Konishi M, Kikuchi-Yanoshita R, Tanaka K, Shitara N, Chong JM, Iwama T and Miyaki M: p300 gene alterations in colorectal and gastric carcinomas. Oncogene. 12:1565–1569. 1996.PubMed/NCBI
48	Gayther SA, Batley SJ, Linger L, Bannister A, Thorpe K, Chin SF, Daigo Y, Russell P, Wilson A, Sowter HM, et al: Mutations truncating the EP300 acetylase in human cancers. Nat Genet. 24:300–303. 2000. View Article : Google Scholar : PubMed/NCBI
49	Ionov Y, Matsui S and Cowell JK: A role for p300/CREB binding protein genes in promoting cancer progression in colon cancer cell lines with microsatellite instability. Proc Natl Acad Sci USA. 101:pp. 1273–1278. 2004; View Article : Google Scholar : PubMed/NCBI
50	Jeong HJ, Jeong JB, Kim DS and de Lumen BO: Inhibition of core histone acetylation by the cancer preventive peptide lunasin. J Agric Food Chem. 55:632–637. 2007. View Article : Google Scholar : PubMed/NCBI
51	Hernandez-Ledesma B and de Lumen BO: Lunasin: A novel cancer preventive seed Peptide. Perspect Medicin Chem. 2:75–80. 2008.PubMed/NCBI
52	Frolov MV and Dyson NJ: Molecular mechanisms of E2F-dependent activation and pRB-mediated repression. J Cell Sci. 117:2173–2181. 2004. View Article : Google Scholar : PubMed/NCBI
53	de Lumen BO: Lunasin: A novel cancer preventive seed peptide that modifies chromatin. J AOAC Int. 91:932–935. 2008.PubMed/NCBI
54	Kuper H, Adami HO and Trichopoulos D: Infections as a major preventable cause of human cancer. J Intern Med. 248:171–183. 2000. View Article : Google Scholar : PubMed/NCBI
55	Allavena P, Garlanda C, Borrello MG, Sica A and Mantovani A: Pathways connecting inflammation and cancer. Curr Opin Genet Dev. 18:3–10. 2008. View Article : Google Scholar : PubMed/NCBI
56	Villegas I, Sanchez-Fidalgo S and Alarcón de la Lastra C: New mechanisms and therapeutic potential of curcumin for colorectal cancer. Mol Nutr Food Res. 52:1040–1061. 2008. View Article : Google Scholar : PubMed/NCBI
57	Hernandez-Ledesma B, Hsieh CC and de Lumen BO: Antioxidant and anti-inflammatory properties of cancer preventive peptide lunasin in RAW 264.7 macrophages. Biochem Biophys Res Commun. 390:803–808. 2009. View Article : Google Scholar : PubMed/NCBI
58	Jia S, Zhang S, Yuan H and Chen N: Lunasin inhibits cell proliferation via apoptosis and reduces the production of proinflammatory cytokines in cultured rheumatoid arthritis synovial fibroblasts. Biomed Res Int. 2015:3468392015. View Article : Google Scholar : PubMed/NCBI
59	Wang W, Dia VP, Vasconez M, de Mejia EG and Nelson RL: Analysis of soybean protein-derived peptides and the effect of cultivar, environmental conditions, and processing on lunasin concentration in soybean and soy products. J AOAC Int. 91:936–946. 2008.PubMed/NCBI
60	Jeong JB, De Lumen BO and Jeong HJ: Lunasin peptide purified from Solanum nigrum L. protects DNA from oxidative damage by suppressing the generation of hydroxyl radical via blocking fenton reaction. Cancer Lett. 293:58–64. 2010. View Article : Google Scholar : PubMed/NCBI
61	Jacobo-Herrera NJ, Pérez-Plasencia C, Camacho-Zavala E, González GF, Urrutia EL, García-Castillo V and Zentella-Dehesa A: Clinical evidence of the relationship between aspirin and breast cancer (review). Oncol Rep. 32:4512014.PubMed/NCBI
62	Giovannucci E and Chan AT: Role of vitamin and mineral supplementation and aspirin use in cancer survivors. J Clin Oncol. 28:4081–4085. 2010. View Article : Google Scholar : PubMed/NCBI
63	Laine L: Review article: Gastrointestinal bleeding with low-dose aspirin-what's the risk? Aliment Pharmacol Ther. 24:897–908. 2006. View Article : Google Scholar : PubMed/NCBI